Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6798188 | 0.83 | ALOX15 (0.49) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL712668 | 0.78 | ALOX15 (0.59) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL7631412 | 0.76 | ALOX15 (0.52) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL11866536 | 0.75 | ALOX15 (0.65) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL13389385 | 0.75 | ALOX15 (0.55) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL229925 | 0.75 | ALOX15 (0.55) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL11412425 | 0.75 | ALOX15 (0.65) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL8062162 | 0.74 | ALOX15 (0.76) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL19681520 | 0.74 | ALOX15 (0.63) | ALOX15ALDH1A1TSHRUSP2TDP1 | |
| SCHEMBL10616732 | 0.74 | ALOX15 (0.63) | ALOX15ALDH1A1TSHRUSP2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040067870-A1 | Fragrance raw materials aldehydes and pro-fragrances having a tertiary alpha carbon atom | THE PROCTER & GAMBLE COMPANY | 2004-04-08 | — | — | US | disclosed |
| EP-1171556-A1 | FRAGRANCE RAW MATERIALS ALDEHYDES AND PRO-FRAGRANCES HAVING A TERTIARY ALPHA CARBON ATOM | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000063329-A1 | FRAGRANCE RAW MATERIALS ALDEHYDES AND PRO-FRAGRANCES HAVING A TERTIARY ALPHA CARBON ATOM | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067870-A1 | Fragrance raw materials aldehydes and pro-fragrances having a tertiary alpha carbon atom | CUTA, TRPA1, HRH1 | ALOX15 1397/4885ALDH1A1 51/4885TSHR 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.